BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 18297361)

  • 1. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
    Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
    Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
    Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
    Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
    Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].
    Elias D; Laurent S; Antoun S; Duvillard P; Ducreux M; Pocard M; Lasser P
    Gastroenterol Clin Biol; 2003 Apr; 27(4):407-12. PubMed ID: 12759682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
    Sugarbaker PH
    Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
    Elias D; Gilly F; Quenet F; Bereder JM; Sidéris L; Mansvelt B; Lorimier G; Glehen O;
    Eur J Surg Oncol; 2010 May; 36(5):456-62. PubMed ID: 20227231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
    Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Saxena A; Yan TD; Chua TC; Morris DL
    Ann Surg Oncol; 2010 May; 17(5):1291-301. PubMed ID: 20039212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
    J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
    Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
    Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Elias D; Honoré C; Ciuchendéa R; Billard V; Raynard B; Lo Dico R; Dromain C; Duvillard P; Goéré D
    Br J Surg; 2008 Sep; 95(9):1164-71. PubMed ID: 18690633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
    Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Alves S; Mohamed F; Yadegarfar G; Youssef H; Moran BJ
    Eur J Surg Oncol; 2010 Dec; 36(12):1156-61. PubMed ID: 20864306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
    Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
    J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.